Ritual’s Post

This new peer-reviewed study from the American Journal of Clinical Nutrition is a great summary of the safety and efficacy challenges in bringing prenatal vitamins to the market. It's complicated to say the least: heavy metals are everywhere and global pollutants, leaving it impossible to be heavy metal free, yet still no federal safety standards exist. I'm proud of the science-first approach we take at Ritual. We never claim to be heavy metal free, we still shed light on this as a safety issue that deserves a closer look, and we have world class safety programs that bring an unprecedented level of transparency to our consumers, through a visible supply chain own our website, to heavy metal test results for protein powder. Is any brand or study perfect? Certainly not, but I welcome the increased focus and conversation about this important topic.

In the realm of men's health, the quest for effective solutions to erectile dysfunction (ED) has been ongoing. With advancements in science and technology, we've witnessed the evolution of ED supplements, paving the way for innovative products like Stiffy Oral Strips. In this comprehensive guide, we delve into why oral strips have emerged as possibly the best method for taking ED supplements in 2024, exploring the benefits, effectiveness, and impact on male performance. https://lnkd.in/g-FZuyhm

𝗨.𝗦. 𝗜𝗻𝘁𝗿𝗮𝘃𝗲𝗻𝗼𝘂𝘀 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/gGScbA-J The healthcare market is expanding due to an aging population increasingly in need of medical interventions, a rise in chronic diseases requiring advanced treatments, and technological advancements enhancing patient care. This growth underscores the urgent demand for innovative healthcare solutions to meet the complex requirements of modern medicine. Aging often brings various health challenges, including chronic conditions like diabetes, cardiovascular disease, and renal failure. Notably, the Population Reference Bureau projected in January 2024 that the American population aged 65 and older would grow from 58 million in 2022 to 82 million by 2050—a 47% increase—further intensifying the need for healthcare resources. *𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁: Total Parenteral Nutrition, Peripheral Parenteral Nutrition *𝗕𝘆 𝗡𝘂𝘁𝗿𝗶𝗲𝗻𝘁𝘀: Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others *𝗕𝘆 𝗘𝗻𝗱-𝘂𝘀𝗲: Home, Hospitals, Infusion Center *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Fresenius Kabi, Pfizer, Baxter International Inc., ICU Medical, Grifols, B. Braun Group, Amphastar Pharmaceuticals, Inc., Athenex, Rockwell Medical, Inc., Exela Pharma Sciences LLC #IntravenousSolutions #USHealthcare #IVTherapy #FluidManagement #PatientHydration #IVFluids #HealthcareInnovation #MedicalInfusions #ChronicCareSolutions #EmergencyCare #NutrientInfusion #ElectrolyteBalance #ParenteralNutrition #CriticalCare #IVSolutionSupply #ClinicalCare #HospitalsAndClinics #PatientTreatment #USMedicalMarket #IVDrugDelivery

⚜️ Unlock the Power of Chromium: A Strategic Approach for Healthcare Professionals ⚜️ Chromium is a crucial trace element with significant implications in managing metabolic health, particularly in diabetes care and weight management. For pharmacists and healthcare providers, understanding its clinical potential is essential in delivering superior patient outcomes. 🟡 Primary Sources: Whole Grains: Barley, oats, whole wheat Vegetables: Broccoli, potatoes Meats & Seafood: Beef, poultry, shellfish 🟢 Key Clinical Benefits: Optimized Glucose Control: Enhances insulin sensitivity, lowers fasting blood glucose—ideal for managing Type 2 diabetes. Weight Management: Stabilizes blood sugar levels, reducing cravings and supporting lean muscle mass. Cardiovascular Support: Improves lipid profiles by lowering LDL cholesterol and enhancing endothelial function. 📈 Boost Your Practice By integrating chromium into your patient care strategies, you can enhance treatment plans, drive better outcomes, and set a new standard in personalized healthcare. 👉 Read the full article for in-depth insights: ( https://lnkd.in/dNGSPC3E) #Chromium #PharmacyInnovation #HealthcareStrategy #DiabetesManagement #PharmacistLeadership #ClinicalExcellence #ChronicCare #HealthOptimization #PatientOutcomes #PharmacyPractice #StrategicHealthcare #PreventiveMedicine #PharmaceuticalCare #ProfessionalGrowth

𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗜𝗕𝗗: 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗧𝗼𝘄𝗮𝗿𝗱𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 – 10𝘁𝗵 𝗘𝗱𝗶𝘁𝗶𝗼𝗻 In this edition, we will explore treatments and lifestyle changes that can help manage symptoms and improve the quality of life for those living with inflammatory bowel disease (IBD). While there is still no known cure, various approaches can make a significant difference 🌟 💊 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Various medications are used to treat IBD, including anti-inflammatory drugs, immunosuppressants, biologics and/or small molecules. These medications can help reduce inflammation and prevent flare-ups 🥗 𝐃𝐢𝐞𝐭 𝐚𝐧𝐝 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧: Personalized nutrition plans developed in collaboration with a dietitian can be beneficial for individuals with IBD. Identifying trigger foods and incorporating nutritional supplements may be part of the plan 🏥 𝐒𝐮𝐫𝐠𝐞𝐫𝐲: In some cases, surgery may be necessary to remove damaged or inflamed tissue in the digestive tract 🧘 𝐒𝐭𝐫𝐞𝐬𝐬 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭: Stress and anxiety can potentially trigger IBD flare-ups. Finding ways to manage stress, such as through exercise, meditation, or therapy can be helpful 💖 𝐋𝐢𝐟𝐞𝐬𝐭𝐲𝐥𝐞 𝐜𝐡𝐚𝐧𝐠𝐞𝐬: Making lifestyle changes, such as giving up smoking and getting regular exercise, can also help manage symptoms and improve overall health It is important to work closely with a healthcare provider to develop a personalized treatment plan for IBD. With proper care and management, many people with IBD are able to live full and active lives. 📚 "Understanding IBD: Bridging Knowledge Towards Disease Prediction and Prevention" is an initiative led by the GlycanTrigger EU Project. It is dedicated to providing comprehensive, accurate, and easily understandable information about #IBD, #lifestylemanagement, and #patientempowerment. 👩🏻⚕️👨🏽⚕️ Let's bridge the gap between knowledge and well-being! 💪 #GlycanTrigger #Glycans #glycotime #IBD #Crohnsdisease #UlcerativeColitis #PatientEmpowerment #HorizonEurope

🎯𝗦𝗲𝗺𝗮𝗴𝗹𝘂𝘁𝗶𝗱𝗲 - 𝗧𝗵𝗲 𝗪𝗲𝗶𝗴𝗵𝘁 𝗟𝗼𝘀𝘀 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗮𝗻𝗱 𝗜𝘁𝘀 𝗡𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 Many experts in obesity medicine are hailing semaglutide as a groundbreaking "game changer." Research studies have shown that this drug, when used in conjunction with a reduced-calorie 🍔diet and regular exercise, facilitates a 15% to 20% reduction in body weight over a span of 68 weeks. Semaglutide, a compound that mimics the body's natural hormonal response to 🙅♀️eating, can transform how people approach food and weight management. Semaglutide may help individuals achieve significant weight loss by effectively curbing appetite and promoting feelings of fullness. ❗️However, a crucial issue must be addressed: as people reduce their overall food intake, they may inadvertently fall short of the essential micro and macronutrients their bodies need. This deficiency can lead to various health problems, highlighting the importance of a well-balanced #diet while losing weight. 🔥Be sure to read our latest blog post to gain a more comprehensive understanding of #semaglutide and its impact on weight loss and nutrition: https://lnkd.in/dTn5pRdq #pharmacovigilance #patientsafety

𝘛𝘩𝘦 𝘨𝘭𝘰𝘣𝘢𝘭 #𝘱𝘳𝘰𝘣𝘪𝘰𝘵𝘪𝘤_𝘥𝘪𝘦𝘵𝘢𝘳𝘺_𝘴𝘶𝘱𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘴_𝘮𝘢𝘳𝘬𝘦𝘵 𝘪𝘴 𝘨𝘢𝘪𝘯𝘪𝘯𝘨 𝘵𝘳𝘢𝘤𝘵𝘪𝘰𝘯 𝘣𝘦𝘤𝘢𝘶𝘴𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘳𝘪𝘴𝘪𝘯𝘨 𝘱𝘳𝘦𝘷𝘢𝘭𝘦𝘯𝘤𝘦 𝘰𝘧 𝘨𝘢𝘴𝘵𝘳𝘰𝘪𝘯𝘵𝘦𝘴𝘵𝘪𝘯𝘢𝘭 𝘢𝘪𝘭𝘮𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘴𝘶𝘳𝘨𝘪𝘯𝘨 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 #𝘣𝘪𝘧𝘪𝘥𝘰𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘶𝘮 𝘪𝘯𝘧𝘢𝘯𝘵𝘪𝘴... 📜As per the recent #market_research_report, published by BlueWeave Consulting, the size of the "𝙂𝙡𝙤𝙗𝙖𝙡 𝙋𝙧𝙤𝙗𝙞𝙤𝙩𝙞𝙘 𝘿𝙞𝙚𝙩𝙖𝙧𝙮 𝙎𝙪𝙥𝙥𝙡𝙚𝙢𝙚𝙣𝙩𝙨 𝙈𝙖𝙧𝙠𝙚𝙩" is projected to grow at a 📈CAGR of 14.15% reaching a value of 💰USD 39.48 billion by 2029. 🌐𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐏𝐝𝐟 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 ➖ https://lnkd.in/gcdHcBTB 📣 𝐌𝐚𝐫𝐤𝐞𝐭 – 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Based on end user, the the market is segmented into infants, children, adults, and geriatric. The adult segment accounts for the largest #market_share. The growth of #probiotic_supplements has been driven by an increase in the incidence of adult gastrointestinal disorders. 👨💼The major key players are, ◾ Lesaffre, ◾ DuPont de Nemours, Inc., ◾ H&M Groupm Symrise, ◾ ProbioFerm, ◾ Dietary Pros, ◾ Chr. Hansen A/S, ◾ BASF SE, ◾ ADM, ◾ Amway, ◾ Abbott, ◾ Bayer AG, ◾ Glanbia Plc, and ◾ Pfizer Inc. #BlueWeave #marketresearch #consulting #pharmaindustry #healthcare #biotechnology #foodsuppliment #dietarysupplements #probioticsuppliments #marketsize #marketshare

Myth: Weight regain is inevitable when coming off a GLP-1! Today Virta Health published data showing it is entirely possible to keep weight off following a GLP-1 deprescription with the right support and tools. I'm proud that Virta continues to be the trailblazer in this space, now the first solution to be able to claim "we can be a GLP-1 offramp" AND have the published data to back that up (without the latter, the former is just a nice story or aspiration). Pharma and the obesity medicine doctors they fund want people to think this must be a lifelong medication. And it certainly may be for a small percentage of patients. But this data now requires us to push back on that narrative and sets the bar for what should be the expectation for those who do require weight loss medication. #obesity #diabetes #glp1s #ozempic #lifestylemedicine #foodismedicine

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟕.𝟏𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟗% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/dwcD-fdb   The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market #growth. #clinicalnutrition #cancercare #nutritionandcancer #oncologynutrition #cancernutrition #clinicaldiet #nutritiontherapy #medicalnutrition #cancerpatients #healthyeating #nutritionsupport 

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟕.𝟏𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟗% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/diT6Ayn3   The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market hashtag#growth. #clinicalnutrition #cancercare #nutritionandcancer #oncologynutrition #cancernutrition #clinicaldiet #nutritiontherapy #medicalnutrition #cancerpatients #healthyeating #nutritionsupport #polaris Polaris Market Research & Consulting